Sheinbaum Denies Overpriced Medicine Claims Amidst Mexico's Hospital Crisis

Mexico City: Sheinbaum Denies Overpriced Medicine Claims Amidst Hospital Shortages Mexico City is facing a critical shortage of medicines in public hospitals, impacting essential treatments nationwide. This comes as President Claudia Sheinbaum firmly denied accusations of overpriced medicine purchases during the López Obrador administration. She stated, "There are no official reports confirming these claims, and we are committed to transparency in pharmaceutical purchases." However, a reporter presented official data revealing irregular contracts totaling at least 1500 million pesos in 2022, involving 19 companies. The reporter's assertion that "medicines were purchased but never delivered" prompted a heated exchange. Sheinbaum countered by attributing such irregularities to the previous administration, emphasizing the current government's commitment to transparency. The ongoing shortage, however, remains a pressing concern for Mexican citizens. The contrast between Sheinbaum's assertions and the evidence of shortages highlights the complexity of the issue.